Abstract: Introduction. Recently several risk scores have been proposed that, beyond traditional risk factors, also include additional inflammatory biomarkers underlying atherothrombosis. The Reynolds Risk Score (RRS) is a point scale assessing the risk of cardiovascular events over 10 years, which takes into account for the first time high-sensitivity C-reactive protein. The aim of this study was to establish clinical usefulness of RRS in men with stable coronary artery disease and preserved left ventricular systolic function. Material and Methods. In total, 119 symptomatic non-diabetic man (mean age 63.9±9.23) who were directed for an elective coronary arteriography were enrolled in the study. Clinical data were collected including the elevated heart rate ≥70 bpm/min, basic laboratory results, placental growth factor and results of coronary angiography. Patients were analyzed related to RRS: low risk <10% (n=50), moderate risk 10-19% (n=46) and high risk >20% (n=23). Results. Opposite to high RRS patients, in the low risk group more often occurred marginal or none atherosclerotic coronary arteries (13% vs. 44%, P=0.0214). The findings have revealed the relationship between the higher risk score and the lower frequency of marginal or no atherosclerotic coronary arteries (OR=0.19, 95%CI 0.05-0.67). Conclusions. The Reynolds Risk Score appears to be useful in men with stable coronary artery disease and preserved left ventricular systolic function in stratifying the severity of coronary atherosclerosis.
Introduction
Recently several risk scores have been proposed that, beyond traditional risk factors, also include additional inflammatory biomarkers, what is related with understanding of the biological processes underlying atherothrombosis [1] [2] [3] . Although inflammation independently associates with future vascular risks, most of used global risk algorithms do not include information on that variable. In 2003, the Center for Disease Control and Prevention and the American Heart Association provided the first general guidelines for the use of inflammatory biomarkers in cardiovascular disease detection [4] . From 54 long-term prospective studies it is known that CRP (C-reactive protein) concentration has continuous associations with the risk of developing coronary heart disease, ischaemic stroke or vascular mortality [5] .
Few years ago, a model was developed for assessing the risk of cardiovascular events and in the next 10 years is was called the Reynolds Risk Score (RRS) [6] . It was initially designed to develop and validate an algorithm for global cardiovascular risk in healthy women.60 years improved global cardiovascular risk prediction and reclassification of risk compared with the traditional Framingham Risk Score (FRS). In view of ongoing inflammatory processes in the wall of the coronary arteries, it seems that the risk scores, which takes into account the hsCRP level, might be especially useful for patients with stable coronary artery disease.
The aim of our study was to determine the clinical usefulness of RRS in men with stable coronary artery disease.
Material and Methods
The study included symptomatic, non-diabetic 119 men (mean age 63.9±9.23), with preserved left ventricular systolic function, who were directed for elective coronary angiography. The following data were analyzed: age, body mass index, smoking status, family history, heart rate, elevated heart rate (≥70 bpm), arterial blood pressure, basic laboratory results (serum lipids level, cholesterol ratio LDL/HDL, creatinine, hsTnT-high sensitivity troponin, hsCRP), and additionally serum concentration of the inflammatory marker-PlGF (placental growth factor), results of coronary angiography and concomitant cardiovascular diseases (arterial hypertension, previous stroke and peripheral arteries disease) were analysed.
PlGF levels were measured using Human PlGF Quantikine Kit Immunassay for in vitro quantitative measurements by ELISA.
The M-mode, 2-dimensional and Doppler echocardiographic examinations and conventional coronary arteriography using a femoral or radial approach were performed. Stenosis ≥50% of the left main and >70% of the three major coronary arteries (left anterior descending artery, left circumflex artery and right coronary artery and their branches), were considered significant and identified as 1-, 2-or 3-vessel disease. Marginal atherosclerotic plaques were defined as stenosis less than 50%. To calculate the sclerotic alteration in coronary arteries we evaluated the degree of luminal obstruction in conventional visual quantification of coronary arteriography.
In all cases, there was calculated value of RRS. The estimates were performed by using the interactive calculator website www.reynoldsriskscore.org. The RRS is composed of age, systolic blood pressure, smoking, total cholesterol and HDL-C, hsCRP, and parental history of MI before age 60 years [7] . RRS estimates the 10-year risk of cardiovascular events, which includes MI, ischemic stroke, coronary revascularization, and cardiovascular death. Patients were analysed depending on the RRS groups: <10% (low risk), 10% to 20% (moderate risk), and ≥20% (high risk) to predict cardiovascular events in the next 10 years.
Investigations were in accordance with the Declaration of Helsinki. The study was approved by Bioethics Committee.
Statistical methods
Statistical analyses were performed using STATISTICA PL software, version 9.0 and SPSS software, version 19. For continuous variables, arithmetic means and standard deviation (SD) or medians and interquartile range were calculated depending on the normality of distribution. For categorical variables the number of observations (N) and fraction (%) were calculated.
Normality was tested using the Shapiro -Wilk's test for normality.
Differences between two independent samples for continuous data were analyzed using U Mann-Whitney's test (since data distribution was different from normal). To compare more than two independent samples the Kruskal-Wallis test or parametric ANOVA (with post-hoc tests) were used. For categorical variables statistical analysis was based upon results of chi-squared test or chi-squared test with Yates' adjustment. P value <0.05 was considered significant.
Results
The baseline characteristics of patients are presented in Table 1 . Most of the studied patients had arterial hypertension (80.67%), 31% were obese, almost half of the population had dyslipidemia (49.58%) and 22% were current smokers. There were not any significant differences between analyzed RRS groups in the basic laboratory tests results, heart rate, PlGF, hsCRP or hsTnT levels ( Table 2, Table 3 ). Also there was not a difference in frequency of arterial hypertension (P=0.3954), dyslipidemia (P=0.4584), peripheral arteries disease (P= 0.7172) or current smoking (P= 0.1323) between all studied RRS groups. Opposite to patients with the high RRS, the low RRS patients were younger and had lower blood pressure and significantly higher frequency of marginal or no atherosclerotic changes in coronary arteries (13% vs. 44%) ( Table 4 ). The relationship between RRS and the severity of coronary artery disease was revealed: the higher RRS the lower frequency of marginal or no atherosclerotic changes in coronary arteries (OR=0.19, 95%CI 0.05-0.67). There was not a correlation between number of atherosclerotic arteries and PlGF level (R= -0.0647; P=0.486).
Discussion
The main finding of our study was that symptomatic non-diabetic middle-aged men with arterial hypertension, dyslipidemia and with low RRS have more often had marginal or no atherosclerotic changes in their coronary arteries in comparison with patients with high RRS. Moreover, the relationship between RRS and severity of atherosclerosis in coronary arteries of these patients was observed. So far there has not been an article, which compared coronary artery angiography results with the RRS in men with stable coronary artery disease. In times of ongoing discussions as to whether to direct some of these patients for invasive diagnostic tests or not, a simple score as RRS appears to be a very useful tool in identification of those with marginal or no changes in coronary arteries. That might help to avoid an invasive diagnosis, which is burdened with complications.
In 2008, Ridker and colleagues analysed also nondiabetic men (N=10,724) in median age 63 years, who were followed up prospectively over 10 years [7] . Authors compared the test characteristics of global model fit, discrimination, calibration, and reclassification in 2 prediction models for incident of cardiovascular events, one based on age, blood pressure, smoking status, total cholesterol, and HDL-C (traditional model) and the other (RRS model) based on these risk factors plus hsCRP and parental history of myocardial infarction before the age of 60 years [7] . For the end point of all cardiovascular events, the RRS had better global fit (P<0.001).
In order to improve risk prediction, the National Education Cholesterol Panel Adult Treatment Program (NCEP ATP III) has taken into account the incidence of diabetes, stroke, aortic aneurysms, and peripheral artery disease for the identification of high-risk individuals [8] . By searching for a better risk stratifying tool, the newer factors (metabolic, inflammatory, parental history) were also taken into account in CARRISMA Score (Cardiovascular Risk Management) [9] , QRISK2 Score (risk score which uses the QRESEARCH database) [10, 11] , National Health and Nutrition Examination Survey (NHANES) [12] and RRS [6] .
The Framingham Heart Study is well known for its 10-year risk score and FRS, for its prediction of cardiovascular disease events in the general population 
Data are expressed as N (%), mean ±SD and ranges or median (Med) and interquartile ranges (IQR) in variables with nonnormal distribution (*). BMIbody mass index;
BPs-systolic blood pressure; BPd-diastolic blood pressure; HA-arterial hypertension; PlGF-placental growth factor; CRPhs-highsensitivity C-reactive protein; hsTnT-high-sensitivity troponin T. CAD-coronary artery disease; PAD-peripheral artery disease [13] . The MESA (Multi-Ethnic Study of Atherosclerosis) was a prospective cohort study examining measures and progression of subclinical atherosclerosis but also conversion to clinical events among 6,814 participants (3,213 men and 3,601 women) who were between 45 to 84 years old, and free of clinical cardiovascular diseases at first examination from 4 different ethnic groups (white, black, Hispanic, and Chinese) in the USA [14] . The distribution of coronary artery calcium (CAC) levels, measured using electron-beam and multi-detector row computer tomography across FRS strata were examined in the MESA participants (total of 5,660 men and women, 79 years old or younger at baseline) by Okwuosa TM et colleagues [15] . They have shown that in very low-risk individuals (FRS≤ 5%), the yield of screening and probability of identifying persons with clinically significant levels of CAC is low, but becomes greater in low-and intermediate-risk persons (FRS 5.1% to 20%) [15] . Similar to their results, in our study patients with the low RRS mostly had marginal or no atherosclerotic changes in coronary arteries. DeFilippis AP et al. compared the association of the FRS and RRS with subclinical atherosclerosis, assessed by incidence and progression of CAC in 5,140 MESA participants (mean age 61±10 years, 47% males, mean follow-up: 3.1±1.3 years) [16] . Both the FRS and RRS were significantly predictive of incidental CAC (relative risk RR=1.40; 95% CI 1.29-1.52 and RR=1.41; 95% CI 1.30-1.54 per 5% increase in risk, respectively) and CAC progression (mean CAC score change=6.92; 95% CI 5.31-8.54 and 6.82; 95% CI: 5.51-8.14 per 5% increase, respectively). Discordance in risk category classification (<10% or >10% per 10-year coronary heart disease risk) occurred in 13.7%, with only the RRS consistently adding predictive value for incidence and progression of CAC. These subclinical atherosclerosis findings were supported by the coronary heart disease events in 5.6 ±7 years of follow-up [16] . This is the only BMI-body mass index; BPd-diastolic blood pressure; PlGF-placental growth factor; CRPhs-high-sensitivity C-reactive protein; hsTnT-high sensitivity troponin. article concerning what is occurring in the coronary arteries with respect of RRS. An important role in cardiovascular risk stratification play also the biomarkers. PlGF is a strong candidate as a biomarker for plaque instability, myocardial ischemia, and prognosis for patients with ACS [17, 18] , and it seems to be useful also in stable coronary artery disease. Therefore we investigated its role in combination with RRS in stable coronary artery disease. We did not reveal a relationship between PlGF level either for the RRS or the severity of atherosclerosis in coronary arteries.
There still do not exist perfect non-invasive methods for predicting both severity of coronary artery disease and the risk of cardiovascular events in stable angina, although it would be of vital importance in new approach in prevention of cardiovascular events. New factors of pathogenesis of the coronary artery disease are still under investigations, such as epicardial adipose tissue (EAT), which is metabolically active tissue that accumulates around the coronary arteries and may contribute to local inflammatory load by increased synthesis of inflammatory cytokines [19] . In view of ongoing inflammatory processes in the wall of the coronary arteries, it seems that the risk scores, which take into account the hsCRP level as RRS, may be helpful in decision process for invasive diagnostic tests such as coronary angiography.
Limitations
The main limitation of this study was the small number of patients. There is also lack of prospective evaluation. The next limitation is that the visual quantification of coronary arteriography lesions did not include quantitative analysis and fractional flow reserve.
Conclusions
It would appear that the Reynolds Risk Score may be considered as a useful stratifying tool in men with stable coronary artery disease and the preserved left ventricular systolic function.
